Fingerprint
Dive into the research topics of 'LDR-Brachytherapy monotherapy appears unsuited for NCCN unfavorable intermediate-risk prostate cancer patients'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Andreas Boehle*, Dorothea Zywietz, Irina Robrahn-Nitschke, Achim Lusch, Inke R. König